(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 17.65% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.58%.
Staar Surgical Co's revenue in 2026 is $230,591,000.On average, 12 Wall Street analysts forecast STAA's revenue for 2026 to be $15,959,208,201, with the lowest STAA revenue forecast at $13,693,462,241, and the highest STAA revenue forecast at $17,993,156,659. On average, 11 Wall Street analysts forecast STAA's revenue for 2027 to be $17,275,380,277, with the lowest STAA revenue forecast at $14,761,421,972, and the highest STAA revenue forecast at $19,565,002,373.
In 2028, STAA is forecast to generate $18,703,969,167 in revenue, with the lowest revenue forecast at $15,938,316,580 and the highest revenue forecast at $20,766,270,538.